These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32472970)

  • 21. Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration.
    Hosoi H; Mushino T; Nishikawa A; Hashimoto H; Murata S; Hatanaka K; Tamura S; Hanaoka N; Shimizu N; Sonoki T
    Int J Hematol; 2018 Jun; 107(6):717-719. PubMed ID: 29671245
    [No Abstract]   [Full Text] [Related]  

  • 22. Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease.
    Jerkins JH; Hamadani M; Zook F; Epperla N; Shaw BE; Saber W; Rizzo JD; Pasquini M; Chhabra S; Drobyski WR; Hari PN; Shah NN
    Am J Hematol; 2017 Oct; 92(10):E610-E611. PubMed ID: 28699171
    [No Abstract]   [Full Text] [Related]  

  • 23. Vedolizumab for treatment of steroid-refractory lower gastrointestinal acute graft-versus-host disease.
    Coltoff A; Lancman G; Kim S; Steinberg A
    Bone Marrow Transplant; 2018 Jul; 53(7):900-904. PubMed ID: 29371686
    [No Abstract]   [Full Text] [Related]  

  • 24. Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.
    Sung AD; Hassan S; Cardona DM; Wild D; Nichols KR; Mehdikhani H; Balmadrid B; Detweiler CJ; Shealy M; Cirrincione C; Li Z; Poleski M; Dalton TE; Siamakpour-Reihani S; Chao NJ; Sullivan KM
    Biol Blood Marrow Transplant; 2018 Apr; 24(4):734-740. PubMed ID: 29246821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved survival in steroid-refractory acute graft versus host disease after non-myeloablative allogeneic transplantation using a daclizumab-based strategy with comprehensive infection prophylaxis.
    Srinivasan R; Chakrabarti S; Walsh T; Igarashi T; Takahashi Y; Kleiner D; Donohue T; Shalabi R; Carvallo C; Barrett AJ; Geller N; Childs R
    Br J Haematol; 2004 Mar; 124(6):777-86. PubMed ID: 15009066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis of clinically diagnosed upper gastrointestinal GVHD and effect of small-dose corticosteroid therapy after related hematopoietic stem cell transplantation].
    Wang LH; Ren HY; Qiu ZX
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):118-9. PubMed ID: 21429380
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of intra-arterial steroid administration in the management of steroid-refractory acute gastrointestinal graft-versus-host disease.
    Tfayli A; Selby G; Maqbool F; Bierbaum W; Hamadani M
    Am J Hematol; 2006 Dec; 81(12):959-62. PubMed ID: 16924649
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infliximab for steroid refractory or dependent gastrointestinal acute graft-versus-host disease in children after allogeneic hematopoietic stem cell transplantation.
    Yang J; Cheuk DK; Ha SY; Chiang AK; Lee TL; Ho MH; Chan GC
    Pediatr Transplant; 2012 Nov; 16(7):771-8. PubMed ID: 22905718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment with placenta-derived decidual stromal cells in a pediatric patient with life-threatening acute gastrointestinal graft-versus-host disease.
    Gustafsson B; Frisk P; Szakos A; Sadeghi B; Ringdén O; Frost BM
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28612364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Prospective Study of Alemtuzumab as a Second-Line Agent for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplantation.
    Khandelwal P; Emoto C; Fukuda T; Vinks AA; Neumeier L; Dandoy CE; El-Bietar J; Chandra S; Davies SM; Bleesing JJ; Jordan MB; Mehta PA; Jodele S; Grimley MS; Kumar A; Myers KC; Marsh RA
    Biol Blood Marrow Transplant; 2016 Dec; 22(12):2220-2225. PubMed ID: 27664325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of severe acute gastrointestinal graft-versus-host disease complicated by cytomegalovirus gastroenteritis with intra-arterial steroid infusion.
    Hirabayashi S; Kondo T; Oka T; Akamatsu Y; Hishizawa M; Shibata T; Kitano T; Takaori-Kondo A
    Ann Hematol; 2016 Aug; 95(8):1373-5. PubMed ID: 27138923
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute gastrointestinal graft-versus-host disease in pediatric patients: serum albumin on day 5 from initiation of therapy correlates with nonrelapse mortality and overall survival.
    Goussetis E; Paisiou A; Kitra V; Peristeri I; Vessalas G; Stefanaki K; Panayotou I; Giamaiou K; Kontou E; Kitzoni M; Dimopoulou MN; Karkelis S; Kafritsa Y; Rapsomaniki E; Papassotiriou I; Tsirigotis P; Roma E; Graphakos S
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1058-66. PubMed ID: 21073975
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study on recombinant humanized anti-CD25 monoclonal antibody used for treating steroid-resistant acute graft versus host disease following allo-hematopoietic stem cell transplantation].
    Li XH; Gao CJ; DA WM; Cao YB; Xu LX; Wu YM; Liu B; Liu ZY; Yan B; Li SW; Yang XL; Wu XX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1535-40. PubMed ID: 24370044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute Graft-versus-Host Disease: Emerging Insights and Updates into Detection, Prevention, and Treatment.
    DiMaggio E
    Pharmacotherapy; 2020 Aug; 40(8):788-807. PubMed ID: 32530080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors.
    Perez LE; Fernandez H; Ayala E; Beato F; Neuger A; Pidala J; Schell MJ; Anasetti C
    Bone Marrow Transplant; 2017 Apr; 52(4):627-629. PubMed ID: 27991896
    [No Abstract]   [Full Text] [Related]  

  • 36. Efficacy of Mesenchymal Stem Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease following Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
    Chen X; Wang C; Yin J; Xu J; Wei J; Zhang Y
    PLoS One; 2015; 10(8):e0136991. PubMed ID: 26323092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment With α-1-Antitrypsin for Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease: A Report of 2 Cases.
    Gerner RR; Feistritzer C; Moschen AR; Kircher B; Moser P; Tilg H; Nachbaur D
    Transplantation; 2016 Dec; 100(12):e158-e159. PubMed ID: 27861298
    [No Abstract]   [Full Text] [Related]  

  • 38. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.
    Locatelli F; Pagliara D
    Pediatr Blood Cancer; 2012 Aug; 59(2):372-6. PubMed ID: 22544533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease.
    Gómez-Almaguer D; Ruiz-Argüelles GJ; del Carmen Tarín-Arzaga L; González-Llano O; Gutiérrez-Aguirre H; Cantú-Rodríguez O; Jaime-Pérez J; Carrasco-Yalán A; Giralt S
    Biol Blood Marrow Transplant; 2008 Jan; 14(1):10-5. PubMed ID: 18158956
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation.
    Minculescu L; Kornblit BT; Friis LS; Schiødt I; Petersen SL; Andersen NS; Sengeloev H
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):600-607. PubMed ID: 29074374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.